VEEV:NYE-Veeva Systems Inc Class A (USD)

COMMON STOCK | Health Information Services |

Last Closing

USD 236.43

Change

-0.53 (-0.22)%

Market Cap

N/A

Volume

0.86M

Analyst Target

USD 304.05
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-03-18 )

Largest Industry Peers for Health Information Services

Symbol Name Price(Change) Market Cap
SOLV Solventum Corp.

+0.15 (+0.20%)

USD 13.78B
DOCS Doximity Inc

-1.12 (-1.79%)

USD 13.23B
WEAV Weave Communications Inc

-0.33 (-2.88%)

USD 0.83B
AMWL American Well Corp

-0.33 (-4.02%)

USD 0.16B
CTEV Claritev Corporation

-0.05 (-0.25%)

N/A
EVH Evolent Health Inc

+0.15 (+1.50%)

N/A
PHR Phreesia Inc

+0.34 (+1.26%)

N/A
TDOC Teladoc Inc

-0.48 (-5.41%)

N/A
FOXO FOXO Technologies Inc.

-0.01 (-5.11%)

N/A

ETFs Containing VEEV

EKG First Trust Nasdaq Lux Di.. 8.93 % 0.00 %

-0.17 (-1.68%)

USD 2.40M
CURG:LSE VanEck Genomics and Healt.. 7.01 % 0.00 %

-0.19 (-1.68%)

USD 5.16M
CURE:XETRA VanEck Genomics and Healt.. 5.89 % 0.00 %

-0.23 (-1.68%)

N/A
FDHT:XETRA 4.82 % 0.00 %

N/A

N/A
FDHT Fidelity Covington Trust .. 4.19 % 0.00 %

-0.23 (-1.68%)

USD 8.72M
FDOC:LSE 4.11 % 0.00 %

N/A

N/A
RISN Inspire Tactical Balanced.. 3.07 % 0.00 %

+0.02 (+-1.68%)

USD 0.08B
MOAT:SW VanEck Morningstar US Sus.. 2.83 % 0.00 %

-0.09 (-1.68%)

N/A
MOTV:LSE VanEck Morningstar US Wid.. 2.74 % 0.00 %

-0.02 (-1.68%)

USD 0.06B
MOTU:LSE VanEck Morningstar US Wid.. 2.62 % 0.00 %

+0.04 (+-1.68%)

USD 0.06B
MHOT:AU VanEck Morningstar Wide M.. 2.57 % 0.00 %

+2.23 (+-1.68%)

N/A
JMID Janus Henderson Mid Cap G.. 2.37 % 0.00 %

-0.44 (-1.68%)

USD 0.02B
GOAT:AU VanEck Morningstar World .. 2.07 % 0.00 %

+0.29 (+-1.68%)

USD 0.04B
WCLD:LSE WisdomTree Cloud Computin.. 1.76 % 0.00 %

-0.17 (-1.68%)

USD 0.32B
PFUT Putnam Sustainable Future.. 1.59 % 0.00 %

-0.39 (-1.68%)

USD 0.31B
IHF iShares U.S. Healthcare P.. 0.00 % 0.43 %

+0.21 (+-1.68%)

N/A
QRH:CA 0.00 % 1.20 %

N/A

N/A
EASI 0.00 % 0.75 %

N/A

N/A
WELL:LSE Hanetf Icav - Han-Gins He.. 0.00 % 0.00 %

+0.01 (+-1.68%)

N/A
GMVM:XETRA VanEck Morningstar US Sus.. 0.00 % 0.00 %

-0.18 (-1.68%)

N/A
VMOM:XETRA 0.00 % 0.00 %

N/A

N/A
CLDL Direxion Daily Cloud Comp.. 0.00 % 0.00 %

-0.22 (-1.68%)

USD 6.89M
LCG Sterling Capital Focus Eq.. 0.00 % 0.00 %

-0.34 (-1.68%)

USD 0.03B
MOGB:LSE VanEck Morningstar US Sus.. 0.00 % 0.00 %

-0.10 (-1.68%)

USD 0.43B

Market Performance

  Market Performance vs. Industry/Classification (Health Information Services) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 12.45% 78% C+ 91% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 12.45% 78% C+ 90% A-
Trailing 12 Months  
Capital Gain 2.82% 75% C 53% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 2.82% 75% C 38% F
Trailing 5 Years  
Capital Gain 60.14% 75% C 48% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 60.14% 75% C 36% F
Average Annual (5 Year Horizon)  
Capital Gain -0.27% 56% F 32% F
Dividend Return -0.27% 56% F 21% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 26.39% 89% A- 39% F
Risk Adjusted Return -1.03% 56% F 21% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

What to not like:
Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector